$RARE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ultragenyx Pharmaceutical Inc.. Get notifications about new insider transactions in Ultragenyx Pharmaceutical Inc. for free.

Page: 1 2 3 4 5 ... 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 28 2021	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	93.20	4,125	384,450	4,125
Jun 28 2021	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	2,145	0	14,445	12.3 K to 14.4 K (+17.44 %)
Jun 28 2021	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	93.20	4,125	384,450	4,125
Jun 28 2021	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	2,145	0	14,445	12.3 K to 14.4 K (+17.44 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Sell	S	113.68	363	41,266	40,506	40.9 K to 40.5 K (-0.89 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	113.67	313	35,579	29,997	30.3 K to 30 K (-1.03 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Sell	S	113.69	363	41,269	50,122	50.5 K to 50.1 K (-0.72 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Chief Accounti ...	Sell	S	113.67	142	16,141	15,031	15.2 K to 15 K (-0.94 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	113.69	363	41,269	106,818	107.2 K to 106.8 K (-0.34 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	115.71	852	98,585	595,200	596.1 K to 595.2 K (-0.14 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	113.67	393	44,672	26,717	27.1 K to 26.7 K (-1.45 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	113.68	307	34,900	27,110	27.4 K to 27.1 K (-1.12 %)
May 10 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	113.67	364	41,376	38,775	39.1 K to 38.8 K (-0.93 %)
May 05 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	107.80	30,000	3,234,000	2,259,741	2.3 M to 2.3 M (-1.31 %)
Apr 21 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	104.28	396	41,295	27,417	27.8 K to 27.4 K (-1.42 %)
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	M	55.00	5,000	275,000	58,000
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	109.09	5,000	545,450	39,139	44.1 K to 39.1 K (-11.33 %)
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Buy	M	55.00	5,000	275,000	44,139	39.1 K to 44.1 K (+12.77 %)
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Chief Accounti ...	Grant	A	0.00	1,500	0	15,044	13.5 K to 15 K (+11.08 %)
Mar 09 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	120.69	3,000	362,070	13,544	16.5 K to 13.5 K (-18.13 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	138.17	4,572	631,713	107,181	111.8 K to 107.2 K (-4.09 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	4,636	0	111,614	107 K to 111.6 K (+4.33 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	5,500	0	106,978	101.5 K to 107 K (+5.42 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Sell	S	138.17	6,198	856,378	50,237	56.4 K to 50.2 K (-10.98 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	4,636	0	56,435	51.8 K to 56.4 K (+8.95 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	5,500	0	51,799	46.3 K to 51.8 K (+11.88 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	138.17	3,970	548,535	30,227	34.2 K to 30.2 K (-11.61 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	4,636	0	34,197	29.6 K to 34.2 K (+15.68 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	5,500	0	29,561	24.1 K to 29.6 K (+22.86 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	A	142.47	4,655	663,198	4,655
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	138.17	732	101,140	16,544	17.3 K to 16.5 K (-4.24 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Grant	A	0.00	1,560	0	17,276	15.7 K to 17.3 K (+9.93 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	138.16	707	97,679	27,813	28.5 K to 27.8 K (-2.48 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	138.17	2,470	341,280	28,520	31 K to 28.5 K (-7.97 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	4,636	0	30,990	26.4 K to 31 K (+17.59 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	5,500	0	26,354	20.9 K to 26.4 K (+26.37 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Sell	S	138.18	4,255	587,956	40,761	45 K to 40.8 K (-9.45 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	4,636	0	44,835	40.2 K to 44.8 K (+11.53 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	5,500	0	40,199	34.7 K to 40.2 K (+15.85 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Dier Mardi	CFO & Executive Vic ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Dier Mardi	CFO & Executive Vic ...	Grant	A	0.00	5,500	0	45,500	40 K to 45.5 K (+13.75 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	138.18	4,543	627,752	39,139	43.7 K to 39.1 K (-10.40 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	4,636	0	43,682	39 K to 43.7 K (+11.87 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	5,500	0	39,046	33.5 K to 39 K (+16.40 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	A	142.47	36,000	5,128,920	36,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	141.80	30,000	4,254,000	2,289,741	2.3 M to 2.3 M (-1.29 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	142.47	16,342	2,328,245	596,052	612.4 K to 596.1 K (-2.67 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	15,453	0	612,394	596.9 K to 612.4 K (+2.59 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	18,000	0	596,941	578.9 K to 596.9 K (+3.11 %)
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	97.85	7,500	733,875	0
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Gift	G	0.00	1,000	0	64,704	65.7 K to 64.7 K (-1.52 %)
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	149.01	7,500	1,117,575	65,704	73.2 K to 65.7 K (-10.25 %)
Feb 23 2021	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	97.85	7,500	733,875	73,204	65.7 K to 73.2 K (+11.41 %)
Feb 03 2021	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	74.69	2,516	187,920	20,854	23.4 K to 20.9 K (-10.77 %)
Feb 02 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	140.36	2,243	314,827	33,546	35.8 K to 33.5 K (-6.27 %)
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	M	55.00	25,000	1,375,000	63,000
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	139.18	25,000	3,479,500	35,789	60.8 K to 35.8 K (-41.13 %)
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Buy	M	55.00	25,000	1,375,000	60,789	35.8 K to 60.8 K (+69.85 %)
Jan 08 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	M	21.00	4,000	84,000	8,000
Jan 08 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	140.65	4,000	562,600	15,716	19.7 K to 15.7 K (-20.29 %)
Jan 08 2021	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Buy	M	21.00	4,000	84,000	20,436	16.4 K to 20.4 K (+24.34 %)
Dec 10 2020	RARE	Ultragenyx Pharmac ...	Ultragenyx Pharmaceutical Inc.	Director	Sell	S	94.97	357,745	33,975,043	2,200,000	2.6 M to 2.2 M (-13.99 %)
Dec 10 2020	RARE	Ultragenyx Pharmac ...	Ultragenyx Pharmaceutical Inc.	Director	Sell	S	105.54	442,255	46,675,593	2,557,745	3 M to 2.6 M (-14.74 %)
Nov 04 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	96.82	30,000	2,904,600	2,359,741	2.4 M to 2.4 M (-1.26 %)
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	9,903	539,714	25,000
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	100.12	9,903	991,488	24,061	34 K to 24.1 K (-29.16 %)
Nov 02 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	9,903	539,714	33,871	24 K to 33.9 K (+41.32 %)
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	97	5,287	34,903
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	100.00	97	9,700	23,968	24.1 K to 24 K (-0.40 %)
Oct 30 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	97	5,287	24,065	24 K to 24.1 K (+0.40 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	92.69	852	78,972	610,189	611 K to 610.2 K (-0.14 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	88.00	262	23,056	35,789	36.1 K to 35.8 K (-0.73 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.00	325	28,600	23,968	24.3 K to 24 K (-1.34 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	87.98	262	23,051	101,478	101.7 K to 101.5 K (-0.26 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Sell	S	88.00	220	19,360	23,370	23.6 K to 23.4 K (-0.93 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Sell	S	88.00	262	23,056	46,299	46.6 K to 46.3 K (-0.56 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Sell	S	88.00	262	23,056	34,699	35 K to 34.7 K (-0.75 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	87.98	146	12,845	16,436	16.6 K to 16.4 K (-0.88 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	EVP, Finance	Sell	S	87.99	375	32,996	97,812	98.2 K to 97.8 K (-0.38 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Sell	S	94.47	2,780	262,627	46,561	49.3 K to 46.6 K (-5.63 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	10,000	545,000	35,000
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	95.00	10,000	950,000	24,293	34.3 K to 24.3 K (-29.16 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	10,000	545,000	34,293	24.3 K to 34.3 K (+41.16 %)
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Dier Mardi	CFO & Executive Vic ...	Option Exercise	A	95.50	40,000	3,820,000	40,000
Oct 13 2020	RARE	Ultragenyx Pharmac ...	Dier Mardi	CFO & Executive Vic ...	Grant	A	0.00	40,000	0	40,000	0 to 40 K
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	48.43	10,000	484,300	17,000
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	90.00	10,000	900,000	24,293	34.3 K to 24.3 K (-29.16 %)
Oct 07 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	48.43	10,000	484,300	34,293	24.3 K to 34.3 K (+41.16 %)
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	48.43	10,000	484,300	27,000
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	85.00	10,000	850,000	24,293	34.3 K to 24.3 K (-29.16 %)
Sep 24 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	48.43	10,000	484,300	34,293	24.3 K to 34.3 K (+41.16 %)
Sep 02 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	82.63	30,000	2,478,900	2,389,741	2.4 M to 2.4 M (-1.24 %)
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	58.74	5,000	293,700	0
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	86.57	5,000	432,850	57,018	62 K to 57 K (-8.06 %)
Aug 25 2020	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	58.74	5,000	293,700	62,018	57 K to 62 K (+8.77 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Option Exercise	M	54.50	10,000	545,000	45,000
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.39	2,370	209,484	24,293	26.7 K to 24.3 K (-8.89 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	88.44	10,000	884,400	26,663	36.7 K to 26.7 K (-27.28 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Buy	M	54.50	10,000	545,000	36,663	26.7 K to 36.7 K (+37.51 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	3,669	177,690	15,312
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	67.55	7,188	485,549	15,812
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	500	35,285	0
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	3,669	324,266	98,187	101.9 K to 98.2 K (-3.60 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	3,669	177,690	101,856	98.2 K to 101.9 K (+3.74 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	7,188	635,275	98,187	105.4 K to 98.2 K (-6.82 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	67.55	7,188	485,549	105,375	98.2 K to 105.4 K (+7.32 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	500	44,190	98,187	98.7 K to 98.2 K (-0.51 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	500	35,285	98,687	98.2 K to 98.7 K (+0.51 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.54	2,560	226,662	98,187	100.7 K to 98.2 K (-2.54 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.24	461	40,679	100,747	101.2 K to 100.7 K (-0.46 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	M	40.37	1,596	64,431	0
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	M	21.00	17,500	367,500	0
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	M	40.37	5,904	238,344	1,596
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Sell	S	85.01	1,596	135,676	2,550	4.1 K to 2.6 K (-38.49 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Buy	M	40.37	1,596	64,431	4,146	2.6 K to 4.1 K (+62.59 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Sell	S	85.01	9,750	828,848	2,550	12.3 K to 2.6 K (-79.27 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Sell	S	85.55	23,404	2,002,212	12,300	35.7 K to 12.3 K (-65.55 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Buy	M	21.00	17,500	367,500	35,704	18.2 K to 35.7 K (+96.13 %)
Aug 11 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Buy	M	40.37	5,904	238,344	18,204	12.3 K to 18.2 K (+48.00 %)
Jul 15 2020	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Sell	S	85.35	40,000	3,414,000	2,419,741	2.5 M to 2.4 M (-1.63 %)
Jul 10 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	M	21.00	2,000	42,000	12,000
Jul 10 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	91.00	2,000	182,000	16,582	18.6 K to 16.6 K (-10.76 %)
Jul 10 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Buy	M	21.00	2,000	42,000	18,582	16.6 K to 18.6 K (+12.06 %)
Jul 10 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	91.00	638	58,058	16,582	17.2 K to 16.6 K (-3.70 %)
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	M	21.00	6,181	129,801	0
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	90.00	6,181	556,290	13,550	19.7 K to 13.6 K (-31.33 %)
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Buy	M	21.00	6,181	129,801	19,731	13.6 K to 19.7 K (+45.62 %)
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Payment of Exercise	F	86.75	260	22,555	23,590	23.9 K to 23.6 K (-1.09 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	M	21.00	5,000	105,000	6,181
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	85.00	5,000	425,000	13,550	18.6 K to 13.6 K (-26.95 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Buy	M	21.00	5,000	105,000	18,550	13.6 K to 18.6 K (+36.90 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Option Exercise	M	21.00	1,500	31,500	14,000
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	81.00	1,500	121,500	17,220	18.7 K to 17.2 K (-8.01 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Buy	M	21.00	1,500	31,500	18,720	17.2 K to 18.7 K (+8.71 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	SVP, Controller and ...	Sell	S	81.00	1,111	89,991	17,220	18.3 K to 17.2 K (-6.06 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Grant	A	0.00	2,550	0	12,300	9.8 K to 12.3 K (+26.15 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Grant	A	0.00	2,550	0	5,550	3 K to 5.6 K (+85.00 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Grant	A	0.00	2,550	0	12,300	9.8 K to 12.3 K (+26.15 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	2,550	0	12,300	9.8 K to 12.3 K (+26.15 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	76.58	4,250	325,465	4,250

Page: 1 2 3 4 5 ... 5 next >